Study on the Optimal Dose of Irinotecan for Patients with Heterozygous Uridine Diphosphate-Glucuronosyltransferase 1A1 (<i>UGT1A1</i>)Ken Konaka, Keisuke Ishizawa, Tatsuhiko Saito et al.|Biological and Pharmaceutical Bulletin|2019Cited by 6